CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
27.23
0.77%
Market Trading Hours* (UTC) Opens on Wednesday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.33
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Schrodinger Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 27.44
Open* 26.98
1-Year Change* 8.22%
Day's Range* 26.72 - 27.37
52 wk Range 15.85-59.24
Average Volume (10 days) 630.76K
Average Volume (3 months) 30.08M
Market Cap 2.50B
P/E Ratio 40.26
Shares Outstanding 81.04M
Revenue 193.79M
EPS 0.86
Dividend (Yield %) N/A
Beta 1.29
Next Earnings Date Nov 1, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Oct 2, 2023 27.44 -0.44 -1.58% 27.88 28.16 27.07
Sep 29, 2023 28.22 0.32 1.15% 27.90 28.37 27.50
Sep 28, 2023 27.28 -0.17 -0.62% 27.45 27.77 27.00
Sep 27, 2023 27.12 -0.23 -0.84% 27.35 28.02 26.81
Sep 26, 2023 27.31 -0.51 -1.83% 27.82 28.25 26.87
Sep 25, 2023 28.18 -0.20 -0.70% 28.38 28.81 27.79
Sep 22, 2023 28.96 -0.71 -2.39% 29.67 30.08 28.60
Sep 21, 2023 29.45 -0.50 -1.67% 29.95 30.23 29.45
Sep 20, 2023 30.67 -0.48 -1.54% 31.15 31.65 30.54
Sep 19, 2023 31.10 -0.17 -0.54% 31.27 31.87 30.80
Sep 18, 2023 31.68 -0.41 -1.28% 32.09 32.22 30.95
Sep 15, 2023 32.76 -0.25 -0.76% 33.01 33.20 32.28
Sep 14, 2023 33.13 -0.12 -0.36% 33.25 33.95 32.77
Sep 13, 2023 33.15 -0.18 -0.54% 33.33 34.33 33.00
Sep 12, 2023 33.61 0.16 0.48% 33.45 33.99 33.45
Sep 11, 2023 33.90 -0.19 -0.56% 34.09 34.49 33.68
Sep 8, 2023 33.83 -0.67 -1.94% 34.50 34.83 33.75
Sep 7, 2023 34.72 -0.13 -0.37% 34.85 35.10 33.95
Sep 6, 2023 35.50 -0.10 -0.28% 35.60 36.27 34.97
Sep 5, 2023 35.69 -0.53 -1.46% 36.22 36.28 34.94

Schrödinger, Inc. Events

Time (UTC) Country Event
Wednesday, November 1, 2023

Time (UTC)

10:59

Country

US

Event

Q3 2023 Schrodinger Inc Earnings Release
Q3 2023 Schrodinger Inc Earnings Release

Forecast

-

Previous

-
Monday, February 26, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 Schrodinger Inc Earnings Release
Q4 2023 Schrodinger Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 180.955 137.931 108.095 85.543 66.639
Revenue 180.955 137.931 108.095 85.543 66.639
Cost of Revenue, Total 79.933 72.311 44.623 36.45 23.702
Gross Profit 101.022 65.62 63.472 49.093 42.937
Total Operating Expense 327.772 249.374 169.011 124.258 94.608
Selling/General/Admin. Expenses, Total 120.954 86.159 59.693 46.291 34.259
Research & Development 126.372 90.904 64.695 38.786 34.215
Operating Income -146.817 -111.443 -60.916 -38.715 -27.969
Interest Income (Expense), Net Non-Operating -2.309 10.635 34.624 12.743 -0.379
Net Income Before Taxes -149.126 -100.808 -26.292 -25.972 -28.348
Net Income After Taxes -149.189 -101.219 -26.637 -25.681 -28.425
Net Income Before Extra. Items -149.186 -100.393 -24.463 -24.571 -28.425
Total Extraordinary Items
Net Income -149.186 -100.393 -24.463 -24.571 -28.425
Income Available to Common Excl. Extra. Items -149.186 -100.393 -24.463 -24.571 -28.425
Income Available to Common Incl. Extra. Items -149.186 -100.393 -24.463 -24.571 -28.425
Diluted Net Income -149.186 -100.393 -24.463 -24.571 -28.425
Diluted Weighted Average Shares 71.1734 70.5949 60.0247 61.4472 61.4472
Diluted EPS Excluding Extraordinary Items -2.09609 -1.4221 -0.40755 -0.39987 -0.46259
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -2.09609 -1.4221 -0.40755 -0.39987 -0.46259
Depreciation / Amortization 0.513 2.731 2.432
Minority Interest 0.003 0.826 2.174 1.11
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 35.189 64.782 56.843 36.98 38.469
Revenue 35.189 64.782 56.843 36.98 38.469
Cost of Revenue, Total 21.379 19.089 18.139 19.779 21.335
Gross Profit 13.81 45.693 38.704 17.201 17.134
Total Operating Expense 96.322 95.283 85.381 83.143 81.942
Selling/General/Admin. Expenses, Total 32.238 35.453 32.7 30.479 29.484
Research & Development 42.705 40.741 34.542 32.885 31.123
Operating Income -61.133 -30.501 -28.538 -46.163 -43.473
Interest Income (Expense), Net Non-Operating 40.654 185.996 1.194 6.501 -3.872
Net Income Before Taxes -16.153 155.495 -27.344 -39.662 -47.653
Net Income After Taxes 4.278 129.136 -27.208 -39.856 -47.686
Minority Interest 0.001 0.003
Net Income Before Extra. Items 4.278 129.136 -27.207 -39.853 -47.686
Net Income 4.278 129.136 -27.207 -39.853 -47.686
Income Available to Common Excl. Extra. Items 4.278 129.136 -27.207 -39.853 -47.686
Income Available to Common Incl. Extra. Items 4.278 129.136 -27.207 -39.853 -47.686
Diluted Net Income 4.278 129.136 -27.207 -39.853 -47.686
Diluted Weighted Average Shares 75.0643 73.8186 71.2716 71.208 71.1619
Diluted EPS Excluding Extraordinary Items 0.05699 1.74937 -0.38174 -0.55967 -0.67011
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.05699 1.74937 -0.38174 -0.55967 -0.67011
Other, Net 4.326 -0.308
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 533.989 625.06 682.978 118.536 104.69
Cash and Short Term Investments 451.087 576.479 642.691 85.83 84.067
Cash & Equivalents 90.474 120.267 202.296 25.986 77.716
Short Term Investments 360.613 456.212 440.395 59.844 6.351
Total Receivables, Net 69.09 40.551 35.378 25.738 18.021
Accounts Receivable - Trade, Net 67.331 40.015 35.012 25.58 17.995
Prepaid Expenses 8.569 5.03 4.409 6.468 2.602
Total Assets 688.587 756.487 746.263 155.27 120.73
Property/Plant/Equipment, Total - Net 120.226 85.409 15.269 19.03 7.967
Property/Plant/Equipment, Total - Gross 134.339 97.764 29.071 29.592 17.4
Accumulated Depreciation, Total -14.113 -12.355 -13.802 -10.562 -9.433
Intangibles, Net 0.587 0 0.015
Long Term Investments 25.683 43.167 45.664 15.366 5.444
Other Long Term Assets, Total 3.311 2.851 2.352 2.338 2.614
Total Current Liabilities 108.799 91.211 73.205 45.02 27.005
Accounts Payable 9.47 8.079 8.398 3.524 2.773
Accrued Expenses 41.398 27.764 19.404 16.442 6.587
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 57.931 55.368 45.403 25.054 17.645
Total Liabilities 240.693 199.416 122.248 57.054 30.603
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 131.883 108.191 49.039 11.993 3.598
Total Equity 447.894 557.071 624.015 98.216 90.127
Preferred Stock - Non Redeemable, Net 0 191.58 161.687
Common Stock 0.714 0.71 0.699 0.061 0.059
Additional Paid-In Capital 828.7 786.964 752.558 11.655 8.915
Retained Earnings (Accumulated Deficit) -379.138 -229.952 -129.559 -105.096 -80.525
Other Equity, Total -2.382 -0.651 0.317 0.016 -0.009
Total Liabilities & Shareholders’ Equity 688.587 756.487 746.263 155.27 120.73
Total Common Shares Outstanding 71.3279 70.9987 69.8777 61.4472 61.4472
Other Current Assets, Total 5.243 3 0.5 0.5
Minority Interest 0.011 0.014 0.004 0.041
Goodwill, Net 4.791
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 603.734 533.989 524.201 556.872 586.168
Cash and Short Term Investments 527.688 451.087 473.556 509.565 525.532
Cash & Equivalents 233.206 90.474 102.817 127.319 117.257
Short Term Investments 294.482 360.613 370.739 382.246 408.275
Total Receivables, Net 60.164 69.09 35.738 31.745 45.594
Accounts Receivable - Trade, Net 60.272 67.331 34.64 30.782 44.086
Prepaid Expenses 11.396 8.569 9.104 12.062 11.542
Other Current Assets, Total 4.486 5.243 5.803 3.5 3.5
Total Assets 838.773 688.587 661.985 687.88 719.537
Property/Plant/Equipment, Total - Net 122.475 120.226 102.217 101.657 89.256
Long Term Investments 101.539 25.683 27.177 21.903 37.002
Other Long Term Assets, Total 6.234 3.311 2.879 1.804 1.334
Total Current Liabilities 123.407 108.799 88.821 85.59 85.532
Accounts Payable 11.987 9.47 10.918 5.263 9.766
Accrued Expenses 33.524 41.398 33.983 32.887 21.995
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 77.896 57.931 43.92 47.44 53.771
Total Liabilities 248.513 240.693 198.875 194.822 188.87
Total Long Term Debt 0 0 0 0 0
Minority Interest 0.011 0.012 0.015 0.003
Other Liabilities, Total 125.106 131.883 110.042 109.217 103.335
Total Equity 590.26 447.894 463.11 493.058 530.667
Common Stock 0.715 0.714 0.712 0.712 0.712
Additional Paid-In Capital 840.446 828.7 818.015 807.827 797.004
Retained Earnings (Accumulated Deficit) -250.002 -379.138 -351.931 -312.078 -264.392
Other Equity, Total -0.899 -2.382 -3.686 -3.403 -2.657
Total Liabilities & Shareholders’ Equity 838.773 688.587 661.985 687.88 719.537
Total Common Shares Outstanding 71.5262 71.3279 71.232 71.1913 71.1366
Goodwill, Net 4.791 4.791 4.791 4.791 4.791
Intangibles, Net 0 0.587 0.72 0.853 0.986
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -149.189 -101.219 -26.637 -25.681 -28.425
Cash From Operating Activities -119.683 -70.669 16.757 -26.059 -23.711
Cash From Operating Activities 4.344 2.847 3.658 3.64 2.894
Non-Cash Items 46.537 23.026 -19.44 -8.313 1.539
Cash Taxes Paid 0.787 0.448 0.381 0.139 0.013
Changes in Working Capital -21.375 4.677 59.176 4.295 0.281
Cash From Investing Activities 90.023 -16.812 -381.721 -53.855 11.194
Capital Expenditures -8.014 -7.167 -2.538 -1.836 -5.259
Other Investing Cash Flow Items, Total 98.037 -9.645 -379.183 -52.019 16.453
Cash From Financing Activities 2.11 7.952 541.274 28.684 80.273
Issuance (Retirement) of Stock, Net 2.11 7.927 541.274 30.442 80.273
Net Change in Cash -27.55 -79.529 176.31 -51.23 67.756
Financing Cash Flow Items 0 0.025 0 -1.758
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 129.136 -149.189 -121.981 -82.125 -34.44
Cash From Operating Activities -31.094 -119.683 -94.741 -64.378 -39.711
Cash From Operating Activities 1.76 4.344 3.202 2.095 0.969
Non-Cash Items -173.143 46.537 36.307 31.31 16.798
Cash Taxes Paid 0.086 0.787 0.462 0.171 0.037
Changes in Working Capital 11.153 -21.375 -12.269 -15.658 -23.038
Cash From Investing Activities 172.202 90.023 78.466 70.626 36.304
Capital Expenditures -3.58 -8.014 -6.668 -3.67 -1.696
Other Investing Cash Flow Items, Total 175.782 98.037 85.134 74.296 38
Cash From Financing Activities 0.867 2.11 1.628 1.304 0.908
Issuance (Retirement) of Stock, Net 0.867 2.11 1.628 1.304 0.908
Net Change in Cash 141.975 -27.55 -14.647 7.552 -2.499
Financing Cash Flow Items 0 0 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Schrödinger, Inc. Company profile

Schrödinger (SDGR) is a computational platform that facilitates the discovery of molecules for drug development and materials design for biopharmaceutical, academic institutions and government laboratories. 

Founded in 1990, Schrödinger is headquartered in New York. The company has customers and collaborators across more than 70 countries. Its collaborators include Agios Therapeutics, Ajax Therapeutics, Bright Angel Therapeutics, Eli Lilly and Company and Sanofi. 

Schrödinger specialises in oncology, antifungal, fibrosis, inflammatory bowel diseases, metabolic diseases, cardiopulmonary diseases, tuberculosis, neurodegenerative disease and more. 

MALT1 inhibitor is a key regulator of physiological antigen receptor signalling in B cells and T cells and are additive to covalent and non-covalent BTK inhibitors. The company announced US Food and Drug Administration (FDA) clearance of an investigational new drug application for SGR-1505, a MALT1 Inhibitor. 

Schrödinger leverages the software platform to advance its collaborative programmes and its novel therapeutics pipeline includes eight compounds that address unmet medical needs and are currently in the clinical development phase.

Schrödinger, Inc. stock began trading on the NASDAQ in 2020 under the ticker symbol SDGR. 

You can track live SDGR share value and price history at Capital.com.

Industry: Software (NEC)

1540 Broadway
24th Floor
NEW YORK
NEW YORK 10036
US

Income Statement

  • Annual
  • Quarterly

News

How to Trade The Triple Top

Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

14:13, 27 September 2023
USA flag on the background of stock charts. Financial system in USA

Q4 lookahead: US indices starting to show signs of trouble?

US indices start to draw attention as traders focus on the outlook for Q4.

07:20, 27 September 2023

USD/JPY Climbs Towards Key Highs

USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

11:32, 26 September 2023

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

People also watch

Oil - Crude

88.33 Price
+0.500% 1D Chg, %
Long position overnight fee 0.0506%
Short position overnight fee -0.0725%
Overnight fee time 21:00 (UTC)
Spread 0.030

BTC/USD

27,454.50 Price
-1.550% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

XRP/USD

0.54 Price
+3.860% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

Gold

1,821.24 Price
-0.370% 1D Chg, %
Long position overnight fee -0.0194%
Short position overnight fee 0.0112%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading